Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts
Apple Academic Press Inc. (Verlag)
978-1-77964-192-2 (ISBN)
- Titel nicht im Sortiment
- Artikel merken
Recognizing that the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate, patient-centered care, this new series of handbooks aims to fill this gap by showcasing the expanded roles and responsibilities of pharmacists. It will be first of its kind to provide comprehensive information about evidence-based pharmacist care, providing the latest research, guidelines, and up-to-date best practices.
This handbook series is unique in that each volume covers a specific topic, such as infectious diseases, gastrointestinal diseases, and cardiovascular diseases (to name just three areas) and will explore the impact of pharmacist care on patients in clinical settings, consider the economics and humanistic outcomes, as well as discuss the challenges and present helpful advice for implementing effective pharmacist care. The volumes will also delve into the implications, methods, and challenges of providing online and distance pharmacist care services for the specific diseases and conditions as well.
Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders focuses on the nuanced world of endocrine, respiratory, and renal diseases and disorders, spotlighting the multifaceted impact of pharmacist care in these areas. The book systematically explores various disease states, from diabetes to chronic kidney disease, emphasizing the critical role pharmacists play in optimizing clinical outcomes, ensuring economic efficiency, and enhancing the humanistic aspects of patient care. Each chapter is meticulously designed to provide evidence-based insights into pharmacist-led interventions and their transformative effects on patient health and healthcare systems. It covers types 1 and 2 diabetes, thyroid disorders, asthma, COPD, rhinitis, cystic fibrosis, acute and chronic kidney disease, glomerulonephritis, and renal dialysis.
Serving as a testament to the indispensable role of pharmacists in healthcare, this volume a valuable resource for healthcare professionals, students, and policymakers, providing a deeper understanding of the significant contributions of pharmacists in managing endocrine, respiratory, and renal disorders.
Volumes in Handbook of Evidence-Based Pharmacist Care
Volume 1: Cardiovascular Diseases
Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders
Volume 3: Gastrointestinal Diseases and Disorders
Volume 4: Arthritis and Psychiatric Diseases and Disorders
Volume 5: System-Specific Infections
Volume 6: Widespread and Transmissible Infections
Volume 7: Skin Diseases and Conditions
Volume 8: Neurological, Hematological, and Urological Diseases and Disorders
Volume 9: Oncological Diseases and Disorders
Volume 10: Diseases and Disorders of Special Populations
Volume 11: Pharmacist Care in Special Services
Volume 12: Advanced Practices in Pharmacist Care
Volume 13: Pharmacist Skills and Competencies
Volume 14: Clinical Pharmacy, Advanced Pharmacist Practice, and Pharmacy Clinics: Case Studies from Around the World
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts, 14-volume set
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 1: Cardiovascular Diseases
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 3: Gastrointestinal Diseases and Disorders
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 4: Arthritis and Psychiatric Diseases and Disorders
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 5: System-Specific Infections
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 6: Widespread and Transmissible Infections
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 7: Skin Diseases and Conditions
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 8: Neurological, Hematological, and Urological Diseases and Disorders
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 9: Oncological Diseases and Disorders
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 10: Diseases and Disorders of Special Populations
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 11: Pharmacist Care in Special Services
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 12: Advanced Practices in Pharmacist Care
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 13: Pharmacist Skills and Competencies
Click here for Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts: Volume 14: Clinical Pharmacy, Advanced Pharmacy Practice, and Pharmacy Clinics: Case Studies from Around the World
Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates (UAE (previously known as Ajman University). He graduated with a bachelor degree in pharmacy (BPharm) from Sana University, Yemen and obtained master and PhD degree in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. Prof. Yaser has many postgraduate programs certificates including: Training to Teach in Medicine 2023 from Harvard Medical School, Harvard University; and Contemporary Approaches to University Teaching from The Council of Australasian University Leaders in Learning and Teaching (CAULLT). Prof. Yaser is a fellow of the Royal Society of Public Health, UK. He has more than 20 years of experience in education, practice, and research in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia. He has held various academic and professional positions, including Deputy Dean for Medical Sciences College; PharmD Program Director, Head of Clinical Pharmacy/Pharmacy Practice Department; Head of Teaching & Learning Committee; Head of Training Committee; Head of Curriculum Committee, etc. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books and 1500 book chapters in books published by Springer, Elsevier, and Taylors & Francis, USA. Prof. Yaser has supervised/co-supervised PhD, master, PharmD, and BPharm students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Yaser taught, prepared, designed, and wrote many pharmacy programs for many universities including Master of Clinical Pharmacy/Pharmacy Practice program; PharmD program and BPharm program; internship/clerkships for Master, PharmD and BPharm programs; more than 30 courses related to clinical pharmacy, pharmacy practice, social pharmacy and patients care. Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety, being listed in the Top 2% Scientists list of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness: Dispensing errors: 1st; Medication errors: 2nd; Drug-related problems: 3rd; Herbal medications: 3rd; Self-Medications: 4th; Medication safety: 7th; Pharmacovigilance: 45th; Adverse Drug Reactions. These accolades reflect his profound impact on the field, significantly advancing pharmacy education, patient care and safety practices.
Chapters by Yaser Mohammed Al-Worafi except where indicated Preface Introduction 1. Type 1 Diabetes Yaser Mohammed Al-Worafi, Omar Alsamani, and Ejaz Mohammed Ahmed 2. Thyroid Disorders 3. Asthma Yaser Mohammed Al-Worafi, Wafa Alsaeedi, and Long Chiau Ming 4. Rhinitis Yaser Mohammed Al-Worafi 5. Cystic Fibrosis Deepa Shakya, Sweta Shrestha, Asmita Priyadarshini Khatiwada, Nita Shrestha, Ali Ahmed, Anil Khadka, Rajeev Shrestha, and Binaya Sapkota 6. Acute Kidney Disease 7. Glomerulonephritis 8. Renal Dialysis Index
| Erscheint lt. Verlag | 21.4.2026 |
|---|---|
| Zusatzinfo | 2 Tables, black and white |
| Verlagsort | Oakville |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Naturwissenschaften ► Biologie | |
| ISBN-10 | 1-77964-192-3 / 1779641923 |
| ISBN-13 | 978-1-77964-192-2 / 9781779641922 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
